Amicus Therapeutics to Present at Upcoming Investor Conferences in May 2021

PHILADELPHIA, May 07, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in upcoming presentations at the following virtual investor conferences in May:

  • Bank of America 2021 Health Care Conference on Wednesday, May 12, 2021 at 1:15 p.m. E.T.
  • UBS Global Healthcare Virtual Conference on Monday, May 24, 2021 at 10:00 a.m. E.T.

A live audio webcast of each presentation can be accessed via the Investors section of the Amicus Therapeutics corporate website at

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at, and follow us on Twitter and LinkedIn.


Andrew Faughnan
Sr. Director, Investor Relations
(609) 662-3809

Diana Moore
Head of Global Corporate Communications
(609) 662-5079


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.